1/2

Anbogen Receives FDA Clearance to Initiate Phase 1/2 Trial of ABT-301 Triplet Therapy for Advanced Colorectal Cancer

TAIPEI, Aug. 4, 2025 /PRNewswire/ -- Anbogen Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has approved…

1 day ago

CORRECTING and REPLACING Hartford Bakery, Inc. Issues Allergy Alert on Undeclared Hazelnuts in Lewis Bake Shop Artisan Style 1/2 Loaf

EVANSVILLE, Ind.--(BUSINESS WIRE)--This updated release corrects the previously reported lot codes included in the press release dated July 10, 2025.…

4 weeks ago